CAPLYTA’S Strong Market Adoption Propels Its Rise As A Leading Antipsychotic Therapy | Delveinsight
Intra-Cellular Therapies' CAPLYTA is making waves in the antipsychotic market, gaining traction as a novel treatment for schizophrenia and bipolar de ...
Walk to Defeat ALS® Marks 25 Years of Honoring and Supporting People Living with ALS
For 25 years, the Walk to Defeat ALS® has brought together individuals and families impacted by ALS, offering hope, ...
Asia Asset Management5d
Has Bain bailed from tussle for Fuji Soft?
The unusually contentious bidding war between US private equity firms Bain Capital and KKR for Tokyo-listed Fuji Soft looks ...
ePHOTOzine5d
'Mitsubishi tanabe pharma europe ltd' Features
In this section you'll find photographic features that explore holidays and photography courses, details about members meetings, trials and tribulations of installing new software along with ...
ePHOTOzine5d
'Mitsubishi tanabe pharma europe ltd' Reviews
Buying the right camera, lens, accessory or software to suit your photography is really important. Our product reviews offer independent views with hands-on opinion and honest verdicts aimed to ...
thearabianpost3d
Bain Capital Nears Acquisition of Mitsubishi’s Pharma Division in $3.2 Billion Deal
Mitsubishi Tanabe Pharma, for over 500 billion yen . This move aligns with Mitsubishi Chemical’s strategy to streamline its operations and concentrate on core sectors such as vehicle electrification, ...
C&EN5d
Mitsubishi Chemical to sell pharma business to Bain
Mitsubishi Tanabe Pharma, to the US investment firm Bain Capital for about $3.3 billion. Mitsubishi Chemical says it will invest proceeds from the sale in green specialty chemicals , which it has ...